Donna M. Wilcock Ph.D. is an Assistant Professor of Medicine in the Division of Neurology at Duke University Medical Center where she studies mouse models of Alzheimer’s disease. She has a particular interest in the role of the neurovascular unit in Alzheimer’s and how that may be impacted by therapeutic interventions, in particular amyloid-beta targeted immunotherapy.

Dr. Wilcock obtained her B.Sc(Hon) in Pharmacology at Cardiff University in the United Kingdom. Following this she completed her Ph.D. studies in Pharmacology and Neuroscience under the mentorship of Dave Morgan Ph.D. at the University of South Florida. Following postdoctoral studies at Albert Einstein College of Medicine and Duke University she was appointed to the research faculty at Duke to continue her scientific studies.

Dr. Wilcock is particularly interested in the cause of microhemorrhage occurrence due to cerebral amyloid angiopathy, CAA, and its exacerbation by immunotherapy against amyloid-beta. Along with this, she is also focused on the roles of neuroinflammation in Alzheimer’s disease in association with CAA. She has funding for her research from the National Institutes of Health and the Alzheimer’s Association.